NO20021732L - N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler - Google Patents

N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler

Info

Publication number
NO20021732L
NO20021732L NO20021732A NO20021732A NO20021732L NO 20021732 L NO20021732 L NO 20021732L NO 20021732 A NO20021732 A NO 20021732A NO 20021732 A NO20021732 A NO 20021732A NO 20021732 L NO20021732 L NO 20021732L
Authority
NO
Norway
Prior art keywords
pro
methods
protein kinase
inflammatory agents
receptor complex
Prior art date
Application number
NO20021732A
Other languages
English (en)
Other versions
NO20021732D0 (no
Inventor
James A Clagett
Craig Palmer
Original Assignee
Histatek Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histatek Llc filed Critical Histatek Llc
Publication of NO20021732D0 publication Critical patent/NO20021732D0/no
Publication of NO20021732L publication Critical patent/NO20021732L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20021732A 1999-10-15 2002-04-12 N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler NO20021732L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15967799P 1999-10-15 1999-10-15
PCT/US2000/028183 WO2001029069A1 (en) 1999-10-15 2000-10-12 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent

Publications (2)

Publication Number Publication Date
NO20021732D0 NO20021732D0 (no) 2002-04-12
NO20021732L true NO20021732L (no) 2002-06-12

Family

ID=22573520

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021732A NO20021732L (no) 1999-10-15 2002-04-12 N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler

Country Status (16)

Country Link
EP (1) EP1222199A4 (no)
JP (1) JP2004507441A (no)
KR (1) KR20020057972A (no)
CN (1) CN100497374C (no)
AU (1) AU8014200A (no)
BR (1) BR0014742A (no)
CA (1) CA2387559A1 (no)
CZ (1) CZ20021342A3 (no)
EA (1) EA200200451A1 (no)
HU (1) HUP0203688A2 (no)
IL (1) IL149125A0 (no)
MX (1) MXPA02003782A (no)
NO (1) NO20021732L (no)
PL (1) PL356096A1 (no)
WO (1) WO2001029069A1 (no)
ZA (1) ZA200202937B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
WO2004100978A1 (en) * 2003-05-13 2004-11-25 Medvet Science Pty. Ltd. A method of modulating cellular transmigration and agents for use therein
WO2007004869A2 (en) 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US20110082091A1 (en) * 2009-09-28 2011-04-07 Theramab Gmbh Method for Preclinical Testing of Immunomodulatory Drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840851D1 (de) * 1997-11-13 2009-07-09 Mowycal Lending Llc Kleine peptide und methoden zur behandlung von asthma und entzündungen

Also Published As

Publication number Publication date
EA200200451A1 (ru) 2002-10-31
PL356096A1 (en) 2004-06-14
JP2004507441A (ja) 2004-03-11
NO20021732D0 (no) 2002-04-12
BR0014742A (pt) 2002-08-27
MXPA02003782A (es) 2002-12-13
WO2001029069A1 (en) 2001-04-26
CA2387559A1 (en) 2001-04-26
ZA200202937B (en) 2003-09-23
IL149125A0 (en) 2002-11-10
CN100497374C (zh) 2009-06-10
EP1222199A1 (en) 2002-07-17
EP1222199A4 (en) 2003-03-12
CN1633447A (zh) 2005-06-29
KR20020057972A (ko) 2002-07-12
AU8014200A (en) 2001-04-30
CZ20021342A3 (cs) 2003-01-15
HUP0203688A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
NO20021732L (no) N-formyl peptid reseptor kompleks med et G-protein kinase signalvei modifikasjonsmiddel og fremgangsmåter for endring avsignaloverföring som fölge av stimulering med pro-inflammatoriskemidler
NO2005007I2 (no) Pemetrexed og farmasoytisk akseptable salter derav
DK1035115T3 (da) 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister
DK0808312T3 (da) Indolderivater som 5-HT-receptorantagonist
NO981477D0 (no) Pyrimidinderivater som 5HT2C-reseptor antagonister
DE69831176D1 (de) Kappa rezeptor opioid peptide
NO2006004I1 (no) Erlotinib hydroklorid og farmasoytisk akseptable salter derav
NO2008001I1 (no) Vildagliptin og farmasoytisk akseptable salter derav
DE69232072D1 (de) Endothelin-rezeptor-antagonisten
DK1224175T3 (da) Benzodiazepinderivater som metabotropiske glutamatreceptorantagonister
AU5274499A (en) Therapeutic chemokine receptor antagonists
ID16742A (id) Antagonis reseptor endotelin
NO20015066L (no) Dobbel avleder og orienteringsanordning for mulitilaterale kompletteringer samt fremgangsmater
ATE258548T1 (de) Adhäsionsrezeptor-antagonisten
NO995482D0 (no) Ergolinderivater og deres anvendelse som somatostatinreseptorantagonister
HK1042099A1 (zh) 人g-蛋白偶聯受體
IL196053A0 (en) Novel human g-protein coupled receptor
AU2001238178A1 (en) Seven-transmembrane proteins/g-protein coupled receptors
HK1044567A1 (zh) 人g-蛋白偶聯受體
DE69616364D1 (de) Endothelinrezeptorantagonisten
EP1233981A4 (en) RECEPTOR COUPLED TO A G-PROTEIN
GB2363793B (en) Molecular cloning of a 7TM receptor (AXOR34) and screening methods thereof
DK1237539T3 (da) Oral oplösning indeholdende galanthamin og et södemiddel
ATE326971T1 (de) Pharmazeutische suspension mit nevirapine hemihydrat
EP1071766A4 (en) HUMAN PROTEIN G COUPLED TO GPR6sb RECEPTOR

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application